Our findings suggest that the SKAP1‐NFATc1‐CXCL8‐NET axis is a novel mechanism underlying colon cancer progression, and that targeting SKAP1 is a potential strategy for colon cancer treatment. This evidence concerns the gene NFATC1 and malignant colon neoplasm.